Beam Therapeutics, Inc. (BEAM)
24.50
+0.11
(+0.45%)
USD |
NASDAQ |
Oct 02, 16:00
24.50
0.00 (0.00%)
After-Hours: 20:00
Beam Therapeutics Market Cap : 2.530B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 2.530B |
| October 01, 2026 | 2.519B |
| September 30, 2026 | 2.525B |
| September 29, 2026 | 2.532B |
| September 28, 2026 | 2.502B |
| September 25, 2026 | 2.506B |
| September 24, 2026 | 2.547B |
| September 23, 2026 | 2.517B |
| September 22, 2026 | 2.678B |
| September 21, 2026 | 2.608B |
| September 18, 2026 | 2.576B |
| September 17, 2026 | 2.548B |
| September 16, 2026 | 2.385B |
| September 15, 2026 | 2.398B |
| September 14, 2026 | 2.491B |
| September 11, 2026 | 2.477B |
| September 10, 2026 | 2.517B |
| September 09, 2026 | 2.600B |
| September 08, 2026 | 2.771B |
| September 04, 2026 | 3.063B |
| September 03, 2026 | 3.042B |
| September 02, 2026 | 3.025B |
| September 01, 2026 | 2.997B |
| August 31, 2026 | 3.039B |
| August 28, 2026 | 3.028B |
| Date | Value |
|---|---|
| August 27, 2026 | 3.148B |
| August 26, 2026 | 3.118B |
| August 25, 2026 | 3.204B |
| August 24, 2026 | 2.925B |
| August 21, 2026 | 3.073B |
| August 20, 2026 | 2.932B |
| August 19, 2026 | 3.002B |
| August 18, 2026 | 2.744B |
| August 17, 2026 | 2.798B |
| August 14, 2026 | 2.762B |
| August 13, 2026 | 2.738B |
| August 12, 2026 | 2.758B |
| August 11, 2026 | 2.773B |
| August 10, 2026 | 2.817B |
| August 07, 2026 | 2.838B |
| August 06, 2026 | 2.814B |
| August 05, 2026 | 2.781B |
| August 04, 2026 | 2.913B |
| August 03, 2026 | 2.662B |
| July 31, 2026 | 2.622B |
| July 30, 2026 | 2.722B |
| July 29, 2026 | 2.673B |
| July 28, 2026 | 2.701B |
| July 27, 2026 | 2.576B |
| July 24, 2026 | 2.579B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Intellia Therapeutics, Inc. | 1.717B |
| Twist Bioscience Corp. | 11.82B |
| Prime Medicine, Inc. | 538.60M |
| Q32 Bio, Inc. | 195.35M |
| Sarepta Therapeutics, Inc. | 1.848B |
Market Cap Related Metrics
| PS Ratio | 16.29 |
| Price to Book Value | 2.370 |
| Price | 24.50 |
| Earnings Yield | -3.51% |